Search results for "Derivative"

showing 10 items of 1074 documents

Implicit analytic solutions for a nonlinear fractional partial differential beam equation

2020

Abstract Analytic solutions in implicit form are derived for a nonlinear partial differential equation (PDE) with fractional derivative elements, which can model the dynamics of a deterministically excited Euler-Bernoulli beam resting on a viscoelastic foundation. Specifically, the initial-boundary value problem for the corresponding PDE is reduced to an initial value problem for a nonlinear ordinary differential equation in a Hilbert space. Next, by employing the cosine and sine families of operators, a variation of parameters representation of the solution map is introduced. Due to the presence of a nonlinear term, a local fixed point theorem is employed to prove the local existence and u…

Numerical AnalysisPartial differential equationApplied MathematicsCosine and sine families of operatorHilbert spacePartial differential equationFractional derivativeVariation of parameters01 natural sciencesImplicit analytic solution010305 fluids & plasmasFractional calculusNonlinear systemsymbols.namesakeModeling and Simulation0103 physical sciencessymbolsPartial derivativeInitial value problemApplied mathematicsBoundary value problem010306 general physicsMathematicsNonlinear beam
researchProduct

Time-harmonic elasticity with controllability and higher-order discretization methods

2008

The time-harmonic solution of the linear elastic wave equation is needed for a variety of applications. The typical procedure for solving the time-harmonic elastic wave equation leads to difficulties solving large-scale indefinite linear systems. To avoid these difficulties, we consider the original time dependent equation with a method based on an exact controllability formulation. The main idea of this approach is to find initial conditions such that after one time-period, the solution and its time derivative coincide with the initial conditions.The wave equation is discretized in the space domain with spectral elements. The degrees of freedom associated with the basis functions are situa…

Numerical AnalysisPhysics and Astronomy (miscellaneous)DiscretizationApplied MathematicsMathematical analysisLinear systemWave equationComputer Science ApplicationsControllabilityComputational Mathematicssymbols.namesakeModeling and SimulationDiagonal matrixTime derivativesymbolsGaussian quadratureSpectral methodMathematics
researchProduct

Conformational properties of N′,N′-dimethylamides of N-acetyldehydroalanine and N-acetyl-(Z)-dehydrophenylalanine

2001

Conformational preferences of Ac-deltaAla-NMe2 and Ac-(Z)-deltaPhe-NMe2 were studied and compared with those of their monomethyl counterparts as well as with those of their saturated analogues. X-Ray data and energy calculations revealed a highly conservative conformation of the dehydro dimethylamides, which is located in a high-energy region of the Ramachandran map.

N¢-dimethylamidesaalanine and phenylalaninederivativesb-dehydroamino acidsGeneral Biochemistry Genetics and Molecular BiologyX-ray crystallographytheoretical calculations
researchProduct

SYNTHESIS OF NEW OLIGOPEPTIDE PYRROLE DERIVATIVES

2008

OLIGOPEPTIDE PYRROLE DERIVATIVESSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Synthesis of the new oligopeptide pyrrole derivative isonetropsin and its one pyrrole unit analogue

2013

We have designed and synthesized isonetropsin and its one pyrrole unit analogue in which the amine and carbonyl groups have been switched in positions 2 and 4, respectively instead of 4 and 2 positions of the natural antibiotic netropsin.

OligopeptideStereochemistryOrganic ChemistryNetropsinBiochemistryPyrrole derivativesDNA minor groove binderchemistry.chemical_compoundDNA minor groove binderschemistryNetropsinmental disordersDrug DiscoveryNetropsin; DNA minor groove binders; Isonetropsin; Oligopeptide pyrroleAmine gas treatingOligopeptide pyrrolepsychological phenomena and processesIsonetropsinPyrroleTetrahedron
researchProduct

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

2017

Purpose Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diagnosed multiple myeloma (NDMM). All studies had PFS as the primary end point, and none were powered for overall survival (OS) as a primary end point. Thus, a meta-analysis was conducted to better understand the impact of lenalidomide maintenance in this setting. Patients and Methods The meta-analysis was conducted using primary-source patient-level data and documentation from three RCTs (Cancer and Leukemia Group B 100104, Gruppo Italiano Malatti…

OncologyMaleCancer ResearchTime FactorsAngiogenesis InhibitorsKaplan-Meier Estimatelaw.invention0302 clinical medicineAutologous stem-cell transplantationMaintenance therapyRandomized controlled triallawRisk FactorsClinical endpointMedicine10. No inequalityLenalidomideAdjuvantMultiple myelomaRandomized Controlled Trials as TopicHematopoietic Stem Cell TransplantationMESH: Angiogenesis Inhibitors/administration & dosageORIGINAL REPORTSMiddle Aged3. Good healthThalidomideAdult; Aged; Angiogenesis Inhibitors; Chemotherapy Adjuvant; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lenalidomide; Maintenance Chemotherapy; Male; Middle Aged; Multiple Myeloma; Randomized Controlled Trials as Topic; Risk Factors; Thalidomide; Time Factors; Transplantation Autologous; Treatment Outcome; Young Adult; Stem Cell TransplantationTreatment OutcomeOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisDisease ProgressionMESH: Multiple Myeloma/therapyFemaleMultiple MyelomaAutologousmedicine.drugAdultmedicine.medical_specialtyMESH: Thalidomide/analogs & derivatives[SDV.CAN]Life Sciences [q-bio]/CancerTransplantation AutologousDisease-Free SurvivalDrug Administration ScheduleMaintenance Chemotherapy03 medical and health sciencesYoung AdultInternal medicineChemotherapyHumansLenalidomideAgedTransplantationbusiness.industrymedicine.diseaseThalidomideTransplantationbusiness030215 immunologyStem Cell Transplantation
researchProduct

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

2012

Background: Scientific data provide the evidence that secondary K-RAS mutations do not occur during anti-epidermal growth factor receptor therapy in colorectal cancer patients. This multicenter phase II prospective study aims to investigate the activity of a retreatment with a cetuximab-based therapy. Patients and methods: We enrolled 39 irinotecan-refractory patients who had a clinical benefit after a line of cetuximab- plus irinotecan-based therapy and then a progression of disease for which underwent a new line chemotherapy and finally, after a clear new progression of disease, were retreated with the same cetuximab- plus irinotecan-based therapy. Results: Median number of therapeutic li…

OncologyMaleLung NeoplasmsColorectal cancerSettore MED/06 - Oncologia Medicamedicine.medical_treatmentAntibodieCetuximab; Clinical trial; Colorectal neoplasms; Phase II; RetreatmentDrug ResistanceCetuximabadverse effects/pharmacology/therapeutic useAdult; Aged; 80 and over; Antibodies; Monoclonal; administration /&/ dosage; Antineoplastic Combined Chemotherapy Protocols; adverse effects/pharmacology/therapeutic use; Camptothecin; administration /&/ dosage/analogs /&/ derivatives; Colorectal Neoplasms; drug therapy/mortality/pathology; Disease-Free Survival; Drug Resistance; Neoplasm; Exanthema; chemically induced; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; drug therapy/mortality/secondary; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Treatment OutcomeColorectal NeoplasmKaplan-Meier EstimateAntineoplastic Combined Chemotherapy ProtocolsMonoclonal80 and overProspective cohort studyadministration /&/ dosageAged 80 and overCetuximabLiver NeoplasmsAntibodies MonoclonalHematologyMiddle AgedChemotherapy regimenPhase IIClinical trialTreatment OutcomeOncologyLiver NeoplasmLymphatic MetastasisRetreatmentchemically inducedFemaleColorectal Neoplasms/ dosage/analogs /&ampmedicine.drugHumanAdultmedicine.medical_specialtyAntibodies Monoclonal HumanizedIrinotecanAntibodiesDisease-Free SurvivalColorectal neoplasmdrug therapy/mortality/secondarySDG 3 - Good Health and Well-beingInternal medicineadministration /&/ dosage/analogs /&/ derivativesmedicine/ dosageHumansProgression-free survivalneoplasmsAgeddrug therapy/mortality/pathologyChemotherapyAntineoplastic Combined Chemotherapy Protocolbusiness.industryLymphatic MetastasiExanthemamedicine.diseasedigestive system diseasesIrinotecanClinical trialLung Neoplasm/ derivativeDrug Resistance Neoplasmadministration /&ampNeoplasmCamptothecinbusinessAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

2014

BACKGROUND: In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose of fingolimod in a cohort of Italian patients with RRMS without alternative therapeutic options. METHODS: Open-label, single arm, multicentre study. After the first dose of fingolimod, patients were observed for 6 hours and had their vital signs monitored hourly. Extended on-site monitoring was provided when required. RESULTS: Of the 906 p…

OncologyMaleNeurologyfingolimod multiple sclerosis treatment first dose safetyadministration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic useImmunosuppressive AgentSphingosineMultiple SclerosiAtrioventricular Blockadministration /&/ dosage/adverse effects/therapeutic useGeneral MedicineMiddle AgedTolerabilityPropylene GlycolFingolimoddrug therapyTolerabilityAnesthesiaCohortAdolescent Adult Atrioventricular Block; chemically induced/epidemiology Drug Therapy; Combination Female Humans Immunosuppressive Agents; administration /&/ dosage/adverse effects/therapeutic use Male Middle Aged Multiple Sclerosis; drug therapy Propylene Glycols; administration /&/ dosage/adverse effects/therapeutic use Sphingosine; administration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic use Young AdultCombinationDrug Therapy CombinationSettore MED/26 - NeurologiaFemaleAtrioventricular block; Bradycardia; Fingolimod; Multiple sclerosis; Safety; Tolerability; Adolescent; Adult; Atrioventricular Block; Drug Therapy Combination; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Propylene Glycols; Sphingosine; Young Adult; Neurology (clinical)SafetyAtrioventricular block Bradicardia Multiple sclerosis Fingolimod Safety TolerabilityImmunosuppressive AgentsResearch ArticleHumanmedicine.drugAdultmedicine.medical_specialtyMultiple SclerosisAdolescentClinical NeurologyYoung AdultFingolimod HydrochlorideInternal medicineBradycardiamedicineHumansNeurochemistryFingolimod Hydrochloridebusiness.industryMultiple sclerosisFingolimodmedicine.diseaseClinical trialPropylene GlycolsAtrioventricular block Bradycardia Multiple sclerosis Fingolimod Safety Tolerabilitychemically induced/epidemiologyNeurology (clinical)business
researchProduct

Galerkin Scheme-Based Determination of Survival Probability of Oscillators With Fractional Derivative Elements

2016

In this paper, an approximate semi-analytical approach is developed for determining the first-passage probability of randomly excited linear and lightly nonlinear oscillators endowed with fractional derivative elements. The amplitude of the system response is modeled as one-dimensional Markovian process by employing a combination of the stochastic averaging and the statistical linearization techniques. This leads to a backward Kolmogorov equation which governs the evolution of the survival probability of the oscillator. Next, an approximate solution of this equation is sought by resorting to a Galerkin scheme. Specifically, a convenient set of confluent hypergeometric functions, related to …

Operations researchMechanical EngineeringFractional derivative02 engineering and technologyCondensed Matter Physics01 natural sciencesFractional calculus020303 mechanical engineering & transportsSurvival Probability0203 mechanical engineeringSurvival probabilityMechanics of MaterialsScheme (mathematics)0103 physical sciencesNonlinear systemsApplied mathematicsFirst PassageSettore ICAR/08 - Scienza Delle CostruzioniGalerkin method010301 acousticsMathematicsJournal of Applied Mechanics
researchProduct

Existence and stability of periodic solutions in a neural field equation

2017

We study the existence and linear stability of stationary periodic solutions to a neural field model, an intergo-differential equation of the Hammerstein type. Under the assumption that the activation function is a discontinuous step function and the kernel is decaying sufficiently fast, we formulate necessary and sufficient conditions for the existence of a special class of solutions that we call 1-bump periodic solutions. We then analyze the stability of these solutions by studying the spectrum of the Frechet derivative of the corresponding Hammerstein operator. We prove that the spectrum of this operator agrees up to zero with the spectrum of a block Laurent operator. We show that the no…

Operator (physics)Mathematical analysisSpectrum (functional analysis)Fréchet derivativeGeneral MedicineEigenfunctionFunctional Analysis (math.FA)Mathematics - Functional AnalysisMathematics - Analysis of PDEsKernel (statistics)Step functionFOS: MathematicsEigenvalues and eigenvectorsAnalysis of PDEs (math.AP)Linear stabilityMathematics
researchProduct